20/08/2014 16:31:33 Free Membership Login

Biota Pharmaceuticals News (NASDAQ:BOTA)

DateTimeSource
Headline
08/01/20149:38AMBWBIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Biota Pharmaceuticals, Inc.
Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Biota Pharmaceuticals, Inc, (Nasdaq: BOTA) violated state or federal laws. Biota Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of anti-infective... More...>>
05/12/20144:42PMPRNUS34% Drop in Biota Pharmaceutical, Inc.'s Stock Price: Law Firm Investigates on Behalf of Shareholders
34% Drop in Biota Pharmaceutical, Inc.'s Stock Price: Law Firm Investigates on Behalf of Shareholders PR Newswire SAN DIEGO and NEW YORK, May 12, 2014 SAN DIEGO and NEW YORK, May 12, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating potential violations of federal securities laws on... More...>>
05/09/20149:42PMPRNUSFaruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Biota Pharmaceuticals, Inc. (BOTA) To ...
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Biota Pharmaceuticals, Inc. (BOTA) To Contact The Firm PR Newswire NEW YORK, May 9, 2014 NEW YORK, May 9, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities... More...>>
04/29/201412:20PMPRNUSSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biota Pharmaceuticals, Inc. - BOTA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biota Pharmaceuticals, Inc. - BOTA PR Newswire NEW YORK, April 29, 2014 NEW YORK, April 29, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biota Pharmaceuticals, Inc. ("Biota" or the "Company") (NASDAQ:... More...>>
12/23/20136:29AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Monday's session are Archer Daniels Midland Co. (ADM), Biota Pharmaceuticals Inc. (BOTA) and Hologic Inc. (HOLX). Archer Daniels Midland has agreed to pay more than $36 million to settle charges under the Foreign Corrupt Practices Act that it failed to prevent... More...>>
10/04/201310:45AMBWFaruqi & Faruqi, LLP Launches An Investigation Against Biota Pharmaceuticals, Inc. (BOTA) For Potential Breaches Of Fiduciary...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Biota Pharmaceuticals, Inc. Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of... More...>>
02/12/20137:00AMMWUSBiota Pharmaceuticals Reports Second Quarter Financial Results and Corporate Update
Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) LANI Influenza Program Advancing Toward Phase 2 Clinical Development Merger between Nabi Biopharmaceuticals and Biota Holdings Limited Successfully Completed Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) today announced its financial results for the three month period ended December... More...>>
11/14/20127:00AMMWUSBiota Pharmaceuticals Announces Appointment of New Executive Officers
Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) today announced the appointment of Russell H. Plumb as its Chief Executive Officer and Joseph M. Patti, M.S.P.H., Ph.D. as Executive Vice President, Corporate Development & Strategy. Mr. Plumb will also join the Board of Directors. "Biota's move to the United States marks the... More...>>
09/19/20129:36PMPRNUSMangrove Partners Agrees to Support Amended Transaction Between Nabi Biopharmaceuticals and Biota Holdings
Mangrove Partners Agrees to Support Amended Transaction Between Nabi Biopharmaceuticals and Biota Holdings Says Improved Transaction Terms Are in Best Interest of Nabi Stockholders and Will Vote in Favor of All Transaction Proposals at Upcoming Special Meeting Terminates Proxy Solicitation in Opposition to the Transaction... More...>>
09/12/20128:31PMPRNUSISS And Glass Lewis Both Recommend That Stockholders Vote Against The Nabi/Biota Merger
ISS And Glass Lewis Both Recommend That Stockholders Vote Against The Nabi/Biota Merger PR Newswire NEW YORK, Sept. 12, 2012 NEW YORK, Sept. 12, 2012 /PRNewswire/ -- The Mangrove Partners Fund, L.P. ("Mangrove Partners"), one of the largest stockholders of Nabi Biopharmaceuticals (NasdaqGS: NABI), announced today that... More...>>
09/07/20129:10AMDJNU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Friday's session are Pandora Media Inc. (P), Smith & Wesson Holding Corp. (SWHC) and Audience Inc. (ADNC). Apple Inc. (AAPL) is in talks to license music for a custom-radio service similar to the popular one operated by Pandora, people familiar with the... More...>>
09/07/20127:09AMDJNU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Friday's session are Audience Inc. (ADNC), Smith & Wesson Holding Corp. (SWHC) and Ulta Salon Cosmetics & Fragrance Inc. (ULTA) Mobile-audio technology firm Audience said Apple Inc. (AAPL) is unlikely to use its processor intellectual property in its... More...>>
09/06/20127:31PMDJNNabi, Biota Consider Former Inhibitex Executive Plumb as New CEO
By Kristin Jones Nabi Biopharmaceuticals (NABI) has entered into "advanced discussions" with flu-drug developer Biota Holdings Ltd. (BTA.AU) to name Russell H. Plumb as chief executive of the combined company after a planned merger. Nabi shares rose 8% in after-hours trading to $1.75. Through Thursday's close, the stock... More...>>
08/16/20129:05AMPRNUSMangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals Urges Fellow Stockholders to Vote Against the Ill-Advised & Value Destroying Transaction with Biota Holdings Limited at the Upcoming Special Meeting PR Newswire NEW YORK, Aug. 16, 2012 NEW YORK, Aug. 16, 2012 /PRNewswire/ -- The Mangrove Partners... More...>>
08/01/20129:36AMDJNUS HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are Garmin Ltd. (GRMN), DreamWorks Animation SKG Inc. (DWA) and Laboratory Corp. of America Holdings (LH). Shares of Garmin traded higher premarket after second-quarter earnings surged 70% as the personal-navigation-devices maker saw strong... More...>>
08/01/20126:58AMDJNU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are DreamWorks Animation SKG Inc. (DWA), Genworth Financial Inc. (GNW) and Career Education Corp. (CECO). DreamWorks Animation SKG's second-quarter earnings slumped 63% as the computer-animation studio struggled to match year-earlier results... More...>>
07/02/20128:17AMDJNNabi Biopharmaceuticals to Buy Back $23 Million of Stock in Self-Tender Offer
By Chelsea Stevenson Nabi Biopharmaceuticals (NABI) intends to repurchase up to $23 million of stock through a modified Dutch auction self-tender offer. A modified "Dutch auction" tender offer allows shareholders to indicate how many shares and at what price they wish to tender their stock. The developer of nicotine addiction... More...>>
04/23/20125:15AMMWUSBiota and Nabi Announce Proposed Merger
Biota Holdings Limited (ASX: BTA) and Nabi Biopharmaceuticals (NASDAQ: NABI) today announced the signing of a Merger Implementation Agreement to form a combined company Biota Pharmaceuticals, listed on NASDAQ and headquartered in the USA. The Biota move to the US is designed to achieve better value recognition through... More...>>
04/22/201211:45PMDJNCORRECT: Australia's Biota, Nabi Pharmaceuticals Plan Merger
Australian drug development company Biota Holdings Ltd. (BTA.AU) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a combined company to be listed on Nasdaq. Biota said in a statement the move to the U.S. was designed to achieve better value recognition and liquidity through a stronger U.S. shareholder... More...>>
04/22/20127:44PMDJNAustralia's Biota, Nabi Pharmaceuticals Plan Merger
Australian drug development company Biota Holdings Ltd. (BTA.AU) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a combined company to be listed on Nasdaq. Biota said in a statement the move to the U.S. was designed to achieve better value recognition and liquidity through a stronger U.S. shareholder... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq bota140820 16:31